Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133668 (US8846711, 12 | US9051321, 12) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133671 (US8846711, 15 | US9051321, 15) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133664 (US8846711, 8 | US9051321, 8) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133673 (US8846711, 17 | US9051321, 17) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133676 (US8846711, 20 | US9051321, 20) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 57 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133681 (US8846711, 25 | US8846711, 26 | US9051321, 25) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM9913 (US8846711, 26 | US9051321, 27) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 78 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133683 (US8846711, 28 | US9051321, 28) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 81 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133666 (US8846711, 10 | US9051321, 10) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133667 (US8846711, 11) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133675 (US8846711, 19 | US9051321, 19) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133661 (US8846711, 5 | US9051321, 5) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 250 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133680 (US8846711, 24 | US9051321, 24) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 260 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133670 (US8846711, 14 | US9051321, 14) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 340 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133684 (US8846711, 27) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133677 (US8846711, 21 | US9051321, 21) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 870 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133672 (US8846711, 16 | US9051321, 16) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 930 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133662 (US8846711, 6) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133665 (US8846711, 9) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133674 (US8846711, 18 | US9051321, 18) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133679 (US8846711, 23 | US9051321, 23) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133669 (US8846711, 13 | US9051321, 13) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.10E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133660 (US8846711, 4 | US9051321, 4) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.30E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133658 (US8846711, 2 | US9051321, 2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133663 (US8846711, 7 | US9051321, 7) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.10E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133678 (US8846711, 22 | US9051321, 22) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.60E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133659 (US8846711, 3 | US9051321, 3 | US9598407, Compound ...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.90E+3 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI (Staphylococcus aureus) | BDBM133657 (US8846711, 1 | US9051321, 1) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | 6.5 | 25 |
Fab Pharma S.A.S. US Patent | Assay Description Compound inhibitory activity of FabI enzyme is measured in vitro by the IC5 so determination using a fluorescence based assay.The protein FabI from S... | US Patent US8846711 (2014) BindingDB Entry DOI: 10.7270/Q2QN65FV | |||||||||||
More data for this Ligand-Target Pair |